InsidersTradesSigma
Browse the full management transaction log of Medytox Solutions, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 26 January 2016 (Disposition). Among the most active insiders: Aella, Ltd.. The full history is free.
Analysts rate Medytox Solutions, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Medytox Solutions, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions in the healthcare sector. It focuses on the research and commercialization of biological and pharmaceutical products.